The term “glymphatic” emerged roughly a decade ago, marking a pivotal point in
neuroscience research. The glymphatic system, a glial-dependent perivascular network …

The identification of an early biomarker to diagnose Alzheimer's disease (AD) remains a
challenge. Neuropathological studies in animal and AD patients have shown that …

Electrochemiluminescence (ECL) biosensors provide a convenient and high sensitivity
method for early disease diagnosis. However, creating luminophore arrays relying on …

En los últimos años la incidencia del deterioro cognitivo ha ido aumentando, en especial la
enfermedad del Alzheimer. Actualmente, no existe cura para esta patología, pero cada vez …

Alzheimer's disease (AD) is a neurodegenerative disorder and the most common form of
dementia. AD is characterized by brain presence of senile plaques, which are formed by …

Among neurodegenerative diseases, Alzheimer's disease (AD) is the most common form of
senile dementia characterized, in its typical form, by immediate memory loss and other …

Background. Recently, a new test (Cuetos-Vega) was developed to detect patients with early
symptoms of Alzheimer's disease (AD). This test is rapid, simple and could diagnose …

El interés por el empleo de nanopartículas (NPs) metálicas como marcas en
inmunosensores electroquímicos, ha experimentado un gran crecimiento en los últimos …